nvl-655
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jun 9, 2022 (NCT05384626)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06765109 | Phase 3 | Jul 17, 2025 | Nuvalent Inc. |
| NCT05384626 | Phase 1/Phase 2 (Phase 2) | Jun 9, 2022 | Nuvalent Inc. |
| NCT06834074 | N/A | — | Nuvalent Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nuvalent Inc. | For profit | 3 | 3 | 3 | 2022 |
1 organizations
Page 1 / 1